The Alzheimer researchers have frequently faced criticism from people regarding the topic of a lack of diversity. Studies often highlight the fact that participant tools are very often white and that they do not accurately reflect the populations that are majorly afflicted by this disease. The African Americans are at a higher risk of developing this disease; however, ironically, they are also the ones who are significantly underrepresented during the conduct of clinical trials and the work of observational studies. A team of researchers at the USC Mark and Mary Stevens Neuroimaging and Informatics Institute at the Keck School of Medicine had recently conducted a study. This study has established a landmark by examining the human brain and discovering how early Alzheimer's proteins manifest themselves across various racial and ethnic groups. Read More: Regular Walk Can Help to Beat Alzheimer’s: Research Understanding Alzheimer's and dementia   The research focused on Alzheimer's disorder of Alzheimer,…